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Objectives
To apply the standard PADUA and RENAL nephrometry
score variables to three-dimensional (3D) virtual models
(VMs) produced from standard bi-dimensional imaging,
thereby creating three-dimensional (3D)-based (PADUA and
RENAL) nephrometry scores/categories for the
reclassification of the surgical complexity of renal masses,
and to compare the new 3D nephrometry score/category
with the standard 2D-based nephrometry score/category, in
order to evaluate their predictive role for postoperative
complications.
Materials and Methods
All patients with localized renal tumours scheduled for
minimally invasive partial nephrectomy (PN) between
September 2016 and September 2018 underwent 3D and
2D nephrometry score/category assessments preoperatively.
After nephrometry score/category evaluation, all the patients
underwent surgery. Chi-squared tests were used to evaluate
the individual patients’ grouping on the basis of the
imaging tool (3D VMs and 2D imaging) used to assess the
nephrometry score/category, while Cohen’s j coefficient was
used to test the concordance between classifications.
Receiver-operating characteristic curves were produced to
evaluate the sensitivity and specificity of the 3D
nephrometry score/category vs the 2D nephrometry score/
category in predicting the occurrence of postoperative
complications. A general linear model was used to perform
multivariable analyses to identify predictors of overall and
major postoperative complications.
Results
A total of 101 patients were included in the study. The
evaluation of PADUA and RENAL nephrometry scores via 3D
VMs showed a downgrading in comparison with the same scores
evaluated with 2D imaging in 48.5% and 52.4% of the cases.
Similar results were obtained for nephrometry categories (29.7%
and 30.7% for PADUA risk and RENAL complexity categories,
respectively). The 3D nephrometry score/category demonstrated
better accuracy than the 2D nephrometry score/category in
predicting overall and major postoperative complications
(differences in areas under the curve for each nephrometry score/
category were statistically significant comparing the 3D VMs
with 2D imaging assessment). Multivariable analyses confirmed
3D PADUA/RENAL nephrometry category as the only
independent predictors of overall (P = 0.007; P = 0.003) and
major postoperative complications (P = 0.03; P = 0.003).
Conclusions
In the present study, we showed that 3D VMs were more
precise than 2D standard imaging in evaluating the surgical
complexity of renal masses according to nephrometry score/
category. This was attributable to a better perception of
tumour depth and its relationships with intrarenal structures
using the 3D VM, as confirmed by the higher accuracy of the
3D VM in predicting postoperative complications.
Keywords
renal cell carcinoma, minimally invasive partial nephrectomy,
nephrometry scores, 3D virtual imaging, HA3D, postoperative
complication, #KidneyCancer, #kcsm
© 2019 The Authors
BJU International © 2019 BJU International | doi:10.1111/bju.14894 BJU Int 2019; 124: 945–954
Published by John Wiley & Sons Ltd. www.bjui.org wileyonlinelibrary.com
Urological Oncology
Introduction
Partial nephrectomy (PN) currently represents the ‘gold
standard’ treatment for T1 renal masses [1], and is
increasingly performed with a minimally invasive approach
[2]. In addition to functional assessment of the kidney [3],
evaluation of the location and anatomical details of the renal
tumour has a primary role in preoperative surgical planning
as these can predict surgical complexity [4].
Over the past decade, several nephrometry classifications, for
example the PADUA and RENAL scores [5,6], have been
developed as tools to describe objectively how complex the
surgical removal of a renal tumour will be, with the
occurrence of postoperative complications being one of the
factors evaluated.
These scores are mostly based on CT images [7]. Despite the
extensive amount of literature supporting a direct correlation
between nephrometry score and PN outcomes, a complete
understanding of the morphological and anatomical
characteristics of renal tumours is potentially suboptimal, the
evaluation being based on two-dimensional (2D) images. A
more complex ‘cognitive’ process, by which the surgeon
envisions a three-dimensional (3D) image by looking at 2D
images in the three spatial axes (axial, coronal and sagittal), is
therefore needed [8].
In recent years, new technological tools are being developed
to allow the creation of 3D virtual models (VMs) from the
processing of standard 2D imaging. With the aid of these
3D VMs, the surgeon can potentially evaluate tumour
location, tumour features and relationships of the tumour
with the vasculature and upper urinary collecting system
(UCS) more precisely, and therefore can assess the surgical
complexity of a PN, thus avoiding the abstraction process
needed when consulting 2D images [9]. These 3D VMs,
however, are still not routinely used in current clinical
practice [10].
The aim of the present study was to apply the standard
PADUA and RENAL nephrometry variables to the 3D VM,
creating 3D-based PADUA and RENAL nephrometry scores
in order to reclassify the surgical complexity of the renal
masses. In addition, we compared the new 3D nephrometry
scores with the standard 2D-based nephrometry scores in
order to assess their role in predicting postoperative
outcomes, focusing on complications.
Materials and Methods
Study Design
Patients with a radiological finding of an organ-confined
renal mass suitable for minimally invasive PN were
prospectively enrolled in this single-centre study conducted
between September 2016 and September 2018.
For inclusion in the study, patients were required to undergo
four-phase (unenhanced, corticomedullary, nephrographic
and urographic phases) contrast-enhanced CT.
Patients with evidence of anatomical abnormalities, such as a
horse-shoe-shaped or ectopic kidney, were excluded. Patients
with preoperative imaging that was inadequate for creating a
3D VM (such as those with CT with a >3-mm acquisition
interval of the slices, or suboptimal difference of
enhancement among the phases) or those with imaging older
than 3 months were also excluded.
Ethical approval from our institutional ethics committee was
not required for the present study as the 3D VMs were used
only for predicting complications and did not influence the
operation in any way.
Three-Dimensional Virtual Model Rendering
Using a platform of software authorized for medical use, CT
images in DICOM format were processed by MEDICS
(Turin, Italy). Firstly, the four-phase CT images were
evaluated by a bio-engineer using a DICOM viewer and the
segmentation process was performed semi-automatically. The
three-dimensional reconstruction obtained was then refined
by a biomedical engineer under the supervision of an
experienced urologist, focusing on the renal vasculature (both
arterial and venous), the UCS, kidney shape and tumour
features. At the end of the process, a hyperaccuracy 3D
(HA3DTM) model was built [8]. Specifically, the renal pedicle
and the tumour-feeding arteries were reconstructed using the
dynamic region-growing method [11]. The course of
extrarenal and intrarenal arteries was reconstructed up to the
segmental arteries. The next step was the creation of the
mathematical HA3D model, a transcription code for the
visualization of the HA3D reconstruction in an interactive
3D-PDF format, which makes the kidney transparent, to
understand the relationship between the tumour and other
intrarenal structures.
Nephrometry Score Assessment
All the CT images and the 3D VMs created from them were
evaluated in order to assess surgical complexity, as classified
by the PADUA and RENAL nephrometry scores.
Four urologists with extensive experience in kidney cancer
surgery visually evaluated both the CT images (in all three
axial projections) and the 3D VMs. For each case included in
the study, two urologists preoperatively assessed both the
standard PADUA and RENAL scores on the basis of the CT
imagess (2D nephrometry score), separately at first and then
together in case of different opinion, until consensus on the
scores was reached. Similarly, the other two urologists
assessed PADUA and RENAL scores on the basis of the 3D
VMs (3D nephrometry score). All of the urologists had
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scored more than 100 renal masses via nephrometry systems
before commencement of the study. Two different pairs of
urologists were included, despite awareness of the risk of
interobserver variability, in order to avoid an individual
urologist being influenced in their evaluation of the cases
with one imaging tool by the evaluation performed with the
other imaging tool.
Assessment of the nephrometry scores for each case was
carried out by visual evaluation because this is the most
widely used and easiest method of providing the surgeon with
a perception of the tumour complexity during surgical
planning.
Based on the scores, the three risk/complexity categories were
determined based on the PADUA (low risk = scores 6–7,
intermediate risk = scores 8–9, and high risk = scores ≥10)
and RENAL (low = scores 4–6, moderate = scores 7–9, and
high complexity = scores 10–12) classifications (2D and 3D
nephrometry categories).
Because a different imaging tool was used to assess the
nephrometry score/category, it was possible to identify four
different groups: Group 0: cases that maintained the same
PADUA/RENAL score value (and consequently category)
irrespective of the imaging tool used; Group 1: cases with a
lower PADUA risk/RENAL complexity category when
moving from the CT assessment to the 3D-based one; Group
2: cases with a lower PADUA/RENAL score from CT
assessment to 3D VM evaluation, but maintaining the same
risk/complexity category; and Group 3: those with a higher
PADUA/RENAL score on the basis of the 3D VM when
compared with CT images.
Figure 1 shows some examples of tumours in which the
nephrometry classifications (both PADUA and RENAL
scores/categories) were assessed via HA3D reconstruction and
bi-dimensional CT (with the HA3D reconstruction, the
nephrometry score was downgraded, maintained or upgraded
(Fig. 1A–C).
Surgical Intervention and Pathological Assessment
All patients underwent a minimally invasive PN performed
by a single expert surgeon. The approach was either
laparoscopic or robot-assisted. For laparoscopic cases, both
transperitoneal and retroperitoneal approaches were used on
the basis of the tumour location (for posteriorly located
tumours a retroperitoneal approach was preferred) or patient
characteristics (e.g. in case of previous extensive abdominal
surgery). A transperitoneal approach was used for all the
robot-assisted cases. The surgical technique included the same
steps in all the cases. For the renal pedicle management,
clamping was performed with bulldog clamps on the main
renal artery or, when feasible, selectively on segmentary
branches [12], or without clamps [13]. The removal of the
tumour was conducted according to the principles of
enucleation/enucleo-resection [14]. The suture of the renal
defect was performed with one or two running monofilament
sutures, using the sliding-clip technique [15]. A dedicated
expert uro-pathologist performed all the histopathological
evaluations of the specimens.
Outcomes
For each patient, we prospectively collected: demographic
data including age, sex, body mass index, comorbidities
classified according to Charlson’s comorbidity index [16] and
American Society of Anesthesiologists score [17], performance
status as assessed by the Eastern Cooperative Oncology
Group [18], and presence of solitary kidney.
Preoperative data included clinical tumour size, side, location,
clinical T stage, surgical complexity according to PADUA and
RENAL scores evaluated via CT and 3D VMs, and standard
laboratory tests, such as haemoglobin level, serum creatinine
level and estimated GFR, as calculated using the Modification
of Diet in Renal Disease formula [19].
Intra-operative data included: technique (laparoscopic or
robot-assisted); approach (transperitoneal vs retroperitoneal);
operating time; management of the renal pedicle; type and
duration of ischaemia; number of clampless procedures; and
estimated blood loss.
Postoperative data included the following: length of hospital
stay; laboratory tests (haemoglobin, serum creatinine and
eGFR); and 90-day postoperative complications, classified
according to the modified Clavien system [20]. Pathological
data included the following: stage according to TNM
classification [21] and histology and grading according to the
WHO and International Society of Urological Pathology [22]
classifications, respectively. In addition, data on positive
surgical margins were recorded.
Statistical Analysis
Means and standard deviations were used to report
continuous variables, and frequencies and proportions for
categorical variables. Mean values for continuous variables
were compared using Student’s t-test.
A chi-squared test was used to compare frequencies and
proportions. To evaluate the concordance between the two
nephrometric score assessments (2D nephrometry score/
category and 3D nephrometry score/category), Cohen’s j
coefficient was calculated (weighted if more than two raters
were considered) [23].
For the evaluation of sensitivity and specificity of the 3D
nephrometry score vs the 2D nephrometry score in predicting
the occurrence of postoperative complications, receiver-
operating characteristic curves were produced.
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Fig. 1 Examples of tumours in which the nephrometry scores have been assessed via hyperaccuracy three-dimensional (HA3D) reconstruction and bi-
dimensional CT. (A) With HA3D reconstruction, the two-dimensional (2D)-based nephrometry scores have been downgraded in both the cases shown.
(B) With HA3D reconstruction, the 2D-based nephrometry scores have been maintained (to denote that it has happened in case of very low and
extremely high complexity cases). (C) The only case of the series in which, with HA3D reconstruction, the 2D-bases nephrometry scores have been
downgraded and upgraded. 3DVM, three-dimensional virtual model; UCS, urinary collecting system.
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A general linear model was used to perform both univariable
and multivariable analyses to identify predictors of overall
postoperative complications.
A P value of <0.05 was taken to indicate statistical
significance. Statistical analysis was performed using SAS
Statistics Software v. 9.3.
Results
A total of 101 patients were included in the study.
Demographics and preoperative characteristics are reported in
Table 1.
Peri-operative and pathological variables are reported in
Table 2. No significant differences were found between the
baseline and 5-day postoperative laboratory test variables. The
median (interquartile range) length of hospital stay was
6 (5;7) days and postoperative complications occurred in 27/
101 patients (26.7%), of which only 6/101(5.9%) were major
complications. Clavien IV complications were not recorded.
Table 3A,B shows the frequencies and proportions of patient
grouping considering all variables, the total PADUA and
RENAL score and the PADUA risk/RENAL complexity
categories, evaluated on the basis of the standard CT and the
3D VMs, respectively. Except for the clinical size category,
polar score and rim location, the distribution of patients was
statistically different for all the PADUA score variables (renal
sinus involvement, UCS invasion, exophytic rate; P < 0.001).
There was a significantly different distribution of patients
between total PADUA score and PADUA risk category (P <
0.001) depending on whether these were calculated on the
basis of the CT or 3D VMs. Similarly, except for ‘radius’, all
the other variables, total RENAL score, and RENAL
complexity categories showed significant differences on the
basis of the imaging tool used (P < 0.001). The Cohen’s j
coefficient values were in line with the P values for each
variable considered.
The reassessment of the patients with regard to PADUA risk/
RENAL complexity categories after 3D VM evaluation is
shown in Fig. 2. With the use of 3D VMs as a nephrometry
score assessment tool, 48.5% and 52.4% of the cases,
respectively, had their PADUA and RENAL score
downgraded. Similarly, for the risk/complexity categories, the
3D VM-based assessment resulted in a reclassification into a
lower category in 29.7% and 30.7% of the PADUA risk and
RENAL complexity categories, respectively. By contrast, the
3D VM assessment led to a higher PADUA and RENAL
score than that obtained from the CT assessment in one
patient only.
Figure 3 shows the ability of each imaging tool-based
nephrometry score and its corresponding risk/complexity
category to predict the risk of overall complications. The
areas under the curve (AUCs) for the 3D nephrometry scores
Table 1 Demographics and preoperative characteristics (N =101).
Age, years, mean (SD) 63 (11.7)
Males, n (%) 74 (73.2)
BMI, mean (SD) 24.7 (1.3)
Charlson's comorbidity index, median (IQR) 1 (0:3)
ASA score, median (IQR) 2 (1:2)
ECOG, median (IQR) 0 (0:1)
Solitary kidney, n (%) 9 (8.9)
Clinical tumour size, mean (SD) 46.1 (18.6)
Tumour side right, n (%) 50 (49.5)





PADUA score, median (IQR) 10 (8:11)
RENAL score, median (IQR) 9 (7:10)
Baseline haemoglobin, mg/dL, mean (SD) 14.1 (1.4)
Baseline serum creatinine, mg/dL, mean (SD) 1.03 (0.2)
Baseline estimated GFR, mL/min/m2, mean (SD) 79.7 (19.8)
ASA, American Society of Anesthesiologists; BMI, body mass index; ECOG, Eastern
Cooperative Oncology Group; IQR, interquartile range.
Table 2 Peri-operative and pathological variables (N = 101).
Surgical technique, n (%)
Laparoscopy 45 (44.6)
Robot-assisted 56 (55.4)
Surgical approach, n (%)
Transperitoneal 61 (60.3)
Retroperitoneal 40 (39.6)
Operating time, min, mean (SD) 104.2 (46.8)
Management of the renal pedicle, n (%)
Main artery clamped 41 (40.6)
Selective clamping 39 (38.6)
Clampless 21 (20.8)
Warm ischaemia time, min, mean (SD) 20.2 (8.7)
Estimated blood loss, mL, mean (SD) 197.7 (186.2)
Hospitalization, days, median (IQR) 6 (5:7)
Haemoglobin 5 days postoperatively, mg/dL, mean (SD) 13.3 (1.5)
Serum creatinine 5 days postoperatively, mg/dL, mean (SD) 1.12 (0.5)
Estimated GFR 5 days postoperatively, mL/min/m2, mean (SD) 68.4 (21.5)
Postoperative complications, n (%) 27 (26.7)
Clavien grade I 10 (9.9)
Clavien grade II 11 (10.9)









ISUP grade, n (%)
Grade 1 8 (7.9)
Grade 2 58 (57.4)
Grade 3 21 (20.7)
Grade 4 1 (0.9)
Not applicable 13 (12.9)
Positive surgical margins, n (%) 2 (1.9)
ISUP, International Society of Urological Pathology.
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were significantly better/higher than the AUCs for their
corresponding 2D nephrometry scores in predicting overall
complications (Fig. 3A). Similar to aforementioned were
found for the AUCs for 3D nephrometry categories and their
corresponding 2D nephrometry categories in predicting the
same outcome (Fig. 3B).
With regard to major complications, Fig. 4 shows the
predictive role of the nephrometry scores and their
corresponding categories based on the same imaging tools.
With regard to 2D nephrometry score and 3D nephrometry
score, both imaging tools were found to be valid in predicting
major complications, with no statistical differences observed
between the assessment tools used (Fig. 4A). Nevertheless,
when looking at the prediction of major complications
according to the nephrometry category assigned (Fig. 4B), the
AUCs for the two imaging tools were found to be statistically
different for both the PADUA risk and the RENAL
complexity category (AUC for 3D-based PADUA risk
category = 0.74 vs AUC for CT-based PADUA risk category
= 0.60, P < 0.001; AUC for 3D-based RENAL complexity
category = 0.83 vs AUC for CT-based RENAL complexity
category = 0.74, P = 0.001).
The multivariable analyses identifying the preoperative









Group 0 Group 1 Group 2 Group 3
RENAL score
Fig. 2 Reassessment of percentage of patients in the different PADUA risk/
RENAL complexity categories after three-dimensional (3D) virtual model
evaluation (Group 0: same nephrometry score; Group 1: reduced
nephrometry score; Group 2: reduced nephrometry score within the same
risk category; Group 3: increased nephrometry score).













(A) PADUA score frequency
Polar location, n (%)
1: Superior/inferior 46 (45.5) 50 (49.5) 0.158 0.84
2: Middle 55 (54.4) 51 (50.5)
Exophytic rate, n (%)
1: ≥50% 45 (44.6) 65 (64.4) <0.001 0.71
2: <50% 39 (38.6) 20 (19.8)
3: Endophytic 17 (16.8) 16 (15.8)
Renal rim, n (%)
1: Lateral 45 (44.5) 50 (49.5) 0.058 0.86
2: Medial 56 (55.4) 51 (50.5)
Renal sinus, n (%)
1: Not involved 25 (24.7) 44 (43.6) <0.001 0.59
2: Involved 76 (75.3) 57 (56.4)
UCS, n (%)
1: Not involved 37 (36.3) 56 (55.5) <0.001 0.52
2: Involved 64 (63.3) 45 (44.5)
Tumour size, n (%)
1: ≤4 cm 42 (41.6) 42 (41.6) 0.319 1
2: 4.1–7 cm 48 (47.5) 48 (47.5)
3: >7 cm 11 (10.9) 11 (10.9)
PADUA score, n (%)
6 7 (6.9) 10 (9.9) <0.001 0.43
7 6 (5.9) 10 (9.9)
8 13 (12.8) 20 (19.8)
9 9 (8.9) 19 (18.8)
10 24 (23.8) 17 (16.8)
11 21 (20.8) 8 (7.9)
12 14 (13.9) 10 (9.9)
13 6 (5.9) 6 (5.9)
14 1 (0.9) 1 (0.9)
PADUA risk category, n (%)
Low risk 13 (12.9) 20 (19.8) <0.001 0.5
Intermediate risk 22 (21.8) 39 (38.6)
High risk 66 (65.3) 42 (41.6)
(B) RENAL score frequency
Radius, n (%)
1: ≤4 cm 42 (41.6) 42 (41.6) 1 1
2: >4 to <7 cm 48 (47.5) 48 (47.5)
3: ≥7 cm 11 (10.9) 11 (10.9)
Exophytic rate, n (%)
1: ≥50% 43 (42.6) 56 (55.4) 0.001 0.80
2: <50% 41 (40.6) 30 (29.7)
3: Endophytic 17 (16.8) 15 (14.9)
Nearness to sinus, n (%)
1: ≥7 mm 9 (8.9) 22 (21.7) <0.001 0.47
2: >4 to <7 mm 24 (23.8) 39 (38.6)
3: ≤4 mm 68 (67.3) 40 (39.6)
Location, polar lines, n (%)
1: Entirely above or below 12 (11.8) 26 (25.8) <0.001 0.59
2: Crosses polar lines 46 (45.5) 48 (47.5)
3: >50% between
polar lines
43 (42.6) 27 (26.7)
RENAL score, n (%)
4 2 (1.9) 8 (7.9) <0.001 0.59
5 5 (4.9) 11 (10.9)
6 9 (8.9) 15 (14.8)
7 12 (11.8) 15 (14.8)
8 21 (20.8) 21 (20.8)
9 26 (25.7) 14 (13.9)
10 19 (18.8) 10 (9.9)
11 6 (5.9) 6 (5.9)














RENAL complexity category, n (%)
Low 16 (15.8) 34 (33.6) <0.001 0.56
Moderate 59 (58.4) 50 (49.5)
High 26 (25.7) 17 (16.8)
3D, three-dimensional; UCS, urinary collecting system; VM, virtual model.
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both for the PADUA risk and RENAL complexity categories,
only the 3D-based assessment was an independent predictor
of postoperative complications (P = 0.007; P = 0.003). Similar
results for both PADUA risk and RENAL complexity
categories were confirmed by the multivariable analyses
evaluating the preoperative independent predictors of major
complications (P = 0.03; P = 0.003 [Table S1]).
Discussion
Over the past decade, in the minimally invasive PN setting
[24], nephrometry scores have been widely implemented in
clinical practice [25,26]; however, results of validation studies
on the predictive role of these tools are still conflicting [27],
and the debate about which of the nephrometry scores more
precisely correlates with peri-operative outcomes is ongoing.
It is also notable that all current nephrometry scores are
calculated based on bi-dimensional imaging [7].
In the present study, we addressed this latter issue by using
3D-modelling technology to determine the anatomical
complexity of renal masses. To do this, we produced 3D VMs
using dedicated professional software and a team of bio-
engineers and urologists working together, as previously
described [8].
Collectively, our findings suggest that 3D imaging gives the
surgeon a more precise understanding of the renal mass
nephrometry details, with a complex structure like the kidney
being easier to be understand three-dimensionally than via bi-
dimensional sliced images.
In fact, the frequencies and proportions of patient
distribution based on nephrometry scores or nephrometry
categories were found to be significantly different between the
CT (2D) and 3D VM assessment (P < 0.001), with a
downgrading of tumour complexity in the 3D groups. Indeed,
for both scores, the 3D VMs led to a reduction in anatomical
complexity scores in approximately half of the patients
(48.5% and 52.4% for PADUA and RENAL score,
respectively).
In addition, from the sub-analysis of the individual variables
included in both the 2D and 3D- based nephrometry scores,
the renal masses classified via 3D VMs were found to be not
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ROC Contrast Estimation and Testing Results by Row ROC Contrast Estimation and Testing Results by Row
ROC (area)
PADUA with CT (0.6722) PADUA with CT (0.5648)
PADUA with 3D (0.7342) PADUA with 3D (0.6867)
RENAL with CT (0.6296) RENAL with CT (0.6289)
RENAL with 3D (0.7125) RENAL with 3D (0.7027)
0.00 0.25 0.50 0.75 1.00
1 - Specificity
0.00
Fig. 3 Receiver-operating characteristic (ROC) curve analysis of overall complications. (A) ROC curve analysis of overall complications considering the
PADUA and RENAL scores evaluated via three-dimensional virtual models (3D VMs) and two-dimensional (2D) CT standard imaging (2D PADUA score:
blue line; 3D PADUA score: red line; 2D RENAL score: green line; 3D RENAL score: brown line). (B) ROC curve analysis of overall complications
considering the PADUA risk and RENAL complexity categories evaluated via 3D VMs and 2D CT standard imaging (2D PADUA risk category: blue line; 3D
PADUA risk category: red line; 2D RENAL complexity category: green line; 3D RENAL complexity category: brown line).
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as deep as the CT images had initially suggested, especially
considering their contact with intrarenal structures such as the
sinus or the UCS (P < 0.001). The discrepancy between CT-
based and 3D-based assessments was also confirmed by the
Cohen’s j coefficient calculation. Indeed, for most of the
individual nephrometry variables included in the calculation of
the final scores and the risk/complexity categories, Cohen’s j
was found to be far from 1, suggesting that the tool selected for
the evaluation of the anatomical complexity can lead to
discordant results, even if the same classification is applied.
Other studies have already evaluated the role of volume
assessment techniques in comparison with CT bi-dimensional
images in evaluating and scoring the nephrometry system,
obtaining almost identical results irrespective of the imaging
tool used [28]. The differences found in the present study can
be explained by the fact that the 3D images obtained were
‘hyper-accurate’ and able to offer to the surgeon more
information regarding the surgical complexity associated with
the tumour than a standard volume assessment obtained
from CT images.
With regard to the clinical implications of these findings, and
specifically the role of the nephrometry score in predicting
postoperative outcomes, the receiver-operating characteristic
curves demonstrated that both the 2D and the 3D
nephrometry score were correlated with overall and major
complications (AUCs calculated with 3D VMs ranging from
0.67 to 0.84), confirming the findings in the literature [29,30].
Nephrometry category, as assessed by the two different
imaging tools, was also considered in order to evaluate
whether the 2D- or 3D-based category was more closely
related to postoperative outcomes. The AUCs (Figs 3B,4B)
showed that the 3D VMs had a significantly higher accuracy
in predicting both overall and major complication occurrence
than the 2D (CT)-based assessment.
These findings were confirmed by multivariable models which
showed the superiority of 3D-based nephrometry categories
in predicting both postoperative and major complications in
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Fig. 4 Receiver-operating characteristic (ROC) curve analysis of major complications. (A) ROC curve analysis of major complications considering the
PADUA and RENAL scores evaluated via three-dimensional virtual model (3D VMs) and two-dimensional (2D) CT standard imaging (2D PADUA score:
blue line; 3D PADUA score: red line; 2D RENAL score: green line; 3D RENAL score: brown line). (B) ROC curve analysis of major complications
considering the PADUA risk and RENAL complexity categories evaluated via 3D VMs and 2D CT standard imaging (2D PADUA risk category: blue line; 3D
PADUA risk category: red line; 2D RENAL complexity category: green line; 3D RENAL complexity category: brown line).
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These results underline that accuracy in evaluating the
surgical complexity of a renal tumour is greatly influenced by
the imaging tool used in the assessment. This is an important
finding because the nephrometry scores included in all other
studies in the current literature are based on 2D imaging.
Accordingly, as they were all based on the same imaging tool,
these studies concluded that the correlation with
postoperative complications was similar for all the
nephrometry scores considered [31]. By contrast, the present
study suggests that the use of a 3D VM as an evaluation tool
is more accurate in classifying the surgical complexity of a
renal mass because it is more strictly predictive of
postoperative complications. This finding represents an
important addition to the current literature because it moves
the focus of the discussion from ‘which is the most accurate
nephrometry score’ to ‘which is the best imaging tool for
tumour complexity evaluation’.
As indicated by the results of previous studies, the present
study underlines how use of the appropriate imaging tool is
fundamental for precise evaluation of the tumour anatomical
complexity in preoperative planning, potentially influencing
the intervention strategy as well as the surgical indication
[32,33].
The present study has some limitations including the fact that
the sample size was limited to 101 cases. In addition, the
inclusion of different urologists for the nephrometry score
assessment increased the risk of interobserver variability.
Furthermore, 3D VMs are still not routinely available in
clinical practice, and require strict collaboration with and
support from biomedical engineers. Another issue in using
this kind of technology is cost. An assessment of the cost-
effectiveness of 3D VMs was not the aim of this study, but
we can suppose that production costs would be likely to
initially limit the diffusion of this technology on a large scale.
Finally, the procedures were performed in a single high-
volume referring centre and therefore the outcomes and
complications might not reflect those obtained in different
settings.
Notwithstanding these limitations, the main strength of this
prospective study is to show for the first time that the
evaluation of the anatomical complexity of a renal mass
strictly depends on the imaging tool used to assess it and not
on the type of nephrometry score chosen. The availability of
3D VMs opens a new chapter in the surgical planning for
PN, allowing more precise and reliable classification of renal
masses, which ultimately can influence the surgical indication.
To confirm and increase the robustness of these findings, a
multi-institutional study is planned.
In conclusion, the present study suggests that 3D VMs are
more accurate than standard 2D CT images in assessing
nephrometry systems, as they provide a better perception of
the tumour location, depth and relationships with intrarenal
structures for the urologists, allowing better inter-rater
agreement and simplifying preoperative planning. The novel
3D-based PADUA and RENAL scores showed higher
accuracy in predicting postoperative complications, when
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